151 results on '"Van Valckenborgh E"'
Search Results
2. Implementation of precision medicine in (routine) cancer care in Belgium in a fair and equitable way
3. Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
4. 181P GeNeo: Agnostic comprehensive genomic profiling versus limited panel organ-directed next-generation sequencing within the Belgian PRECISION initiative
5. 1725P Genetic counselling for cancer in EU member states: Review and foundation for consensus recommendations
6. Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
7. Tumor-initiating capacity of CD138− and CD138+ tumor cells in the 5T33 multiple myeloma model
8. Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation
9. The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models
10. Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells
11. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients
12. Targeting an MMP-9-activated prodrug to multiple myeloma-diseased bone marrow: a proof of principle in the 5T33MM mouse model
13. Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138 + MM-cell proliferation
14. The Effect of JNJ-26481585 in Murine Myeloma Models: B144
15. Probing the Stem Cell in the 5T33 Multiple Myeloma Model: B216
16. BMSC-induced Drug Resistance by Arresting MM Cells at First Contact: B145
17. Perspectives on the integration of Immuno-Oncology Biomarkers and drugs in a Health Care setting
18. The myeloma stem cell concept, revisited: from phenomenology to operational terms
19. RASSF4 functions as a tumor suppressor in Multiple Myeloma
20. Imaging and radioimmunotherapy of multiple myeloma with anti-idiotypic Nanobodies
21. P01-24 The combination of the IGF-1 receptor inhibitor picropodophylin (PPP) and the BH3 mimetic ABT-737 has synergistic anti-myeloma activity
22. Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation
23. Bone marrow endothelial cells as active players in the pathobiology of multiple myeloma
24. Thymosin 4 has tumor suppressive effects and its decreased expression results in poor prognosis and decreased survival in multiple myeloma
25. B144 The Effect of JNJ-26481585 in Murine Myeloma Models
26. B145 BMSC-induced Drug Resistance by Arresting MM Cells at First Contact
27. B216 Probing the Stem Cell in the 5T33 Multiple Myeloma Model
28. Design of mechanisms of selective prodrug activation in the bone marrow microenvironment of experimental and human multiple myeloma
29. Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma
30. Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo
31. Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model.
32. Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium.
33. Genetic counselling legislation and practice in cancer in EU Member States.
34. Precision cancer medicine: What has translated into clinical use in Belgium?
35. NGS for (Hemato-) Oncology in Belgium: Evaluation of Laboratory Performance and Feasibility of a National External Quality Assessment Program.
36. Standardization of Somatic Variant Classifications in Solid and Haematological Tumours by a Two-Level Approach of Biological and Clinical Classes: An Initiative of the Belgian ComPerMed Expert Panel.
37. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
38. Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway.
39. Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
40. Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion.
41. Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
42. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential.
43. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity.
44. Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy.
45. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
46. Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma.
47. Novel strategies to target the ubiquitin proteasome system in multiple myeloma.
48. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
49. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells.
50. Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.